Bone Mineral Density Concerns Should Not Discourage Use Of Contraceptive Shot Concerns about the effects of depot medroxyprogesterone acetate (DMPA)-the contraceptive shot-on bone mineral density (BMD) should not prevent clinicians from prescribing this method of contraception nor should its use be limited to two years, according to a new Committee Opinion released today by The American College of Obstetricians and Gynecologists (ACOG).
Source: www.medicalnewstoday.comNew Approach To Treating Endometrial Cancer Discovered By TGen And Washington University Researchers Researchers at the Translational Genomics Research Institute (TGen) has announced a new approach to treating endometrial cancer patients that not only stops the growth of tumors, but kills the cancer cells. In a potentially major breakthrough, TGen scientists and collaborators at Washington University School of
Medicine in St.
Source: www.medicalnewstoday.com1,500 Professionals From The Biotechnology Sector Will Participate In Biospain 2008 Around 1,500 professionals from the biotechnology sector, coming from 35 countries, will take part in BIOSPAIN 2008, internationally one of the most important events of the sector, which will open its doors from September 17th to 19th in Granada's Congress and Exhibition Centre (Palacio de Congresos. Avda. del Violón, s/n).
Source: www.medicalnewstoday.com
# posted by Network @ 10:00 AM
